fda warning glp-1 november 2025 The growing availability of compounded weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration GLP-1 prescribing among teens with

Our approach includes personalized treatment plans, regular check-ins, body-composition tracking, and lifestyle coaching to help you achieve long-term successnot just short-term results

In this edition of our Ask Dr

For a 75 g oral glucose load this usually requires about 25 g of glucose

Understanding this prognosis in detail can help manage expectations and reduce the anxiety that often accompanies the experience

4.3 Strengths and limitations Strengths of the present review include an extremely rigorous search strategy intended to capture the full range of publications presenting data on this topic

Recent reports suggest that as of 2022, 12% of adults in the United States have taken a GLP-1 agonist for weight loss at some point